title: SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
abstract: Selenoproteins are a class of proteins containing a selenocysteine residue, many of which have been shown to have redox functions, acting as antioxidants to decrease oxidative stress. Selenoproteins have previously been associated with risk of various cancers and redox-related diseases. In this study we evaluated possible associations between breast cancer risk and survival and single nucleotide polymorphisms (SNPs) in the selenoprotein genes GPX1, GPX2, GPX3, GPX4, SELS, SEP15, SEPN1, SEPP1, SEPW1, TXNRD1, and TXNRD2 among Hispanic/Native American (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study. Adaptive Rank Truncated Product (ARTP) analysis was used to determine both gene and pathway significance with these genes. The overall selenoprotein pathway PARTP was not significantly associated with breast cancer risk (PARTP = 0.69), and only one gene, GPX3, was of borderline significance for the overall population (PARTP =0.09) and marginally significant among women with 0-28% Native American (NA) ancestry (PARTP=0.06). The SEPP1 gene was statistically significantly associated with breast cancer risk among women with higher NA ancestry (PARTP=0.002) and contributed to a significant pathway among those women (PARTP=0.04). GPX1, GPX3, and SELS were associated with Estrogen Receptor-/Progesterone Receptor+ status (PARTP = 0.002, 0.05, and 0.01, respectively). Four SNPs (GPX3 rs2070593, rsGPX4 rs2074451, SELS rs9874, and TXNRD1 rs17202060) significantly interacted with dietary oxidative balance score after adjustment for multiple comparisons to alter breast cancer risk. GPX4 was significantly associated with breast cancer survival among those with the highest NA ancestry (PARTP = 0.05) only. Our data suggest that SEPP1 alters breast cancer risk among women with higher levels of NA ancestry.
authors.affiliation: University of Utah, Department of Medicine, Salt Lake City, Utah, United States of America.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Pellatt
authors.forename: Roger K
authors.initials: RK
authors.lastname: Wolff
authors.forename: Esther M
authors.initials: EM
authors.lastname: John
authors.forename: Gabriela
authors.initials: G
authors.lastname: Torres-Mejia
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Hines
authors.forename: Kathy B
authors.initials: KB
authors.lastname: Baumgartner
authors.forename: Anna R
authors.initials: AR
authors.lastname: Giuliano
authors.forename: Abbie
authors.initials: A
authors.lastname: Lundgreen
authors.forename: Martha L
authors.initials: ML
authors.lastname: Slattery
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007198:Indians, North American; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D051149:Selenoprotein P / Q000235:genetics*; D012935:Social Justice; D014481:United States / Q000453:epidemiology
chemical_list: D051149:Selenoprotein P